Deutsch Website, wo Sie Qualität und günstige https://medikamenterezeptfrei2014.com/ Viagra Lieferung weltweit erwerben.

Zufrieden mit dem Medikament, hat mich die positive Meinung priligy kaufen Viagra empfahl mir der Arzt. Nahm eine Tablette etwa eine Stunde vor der Intimität, im Laufe der Woche.

Http://msds.qhse.bayercropscien.pdf

SAFETY DATA SHEET according to EC Directive 2001/58/EC 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE
COMPANY/UNDERTAKING

Product information
Bayer CropScience LimitedHauxtonCambridgeCambridgeshire CB2 5HUUnited Kingdom 2. COMPOSITION/INFORMATION ON INGREDIENTS
Chemical nature
Suspension concentrate (=flowable concentrate)(SC), contains:31% Propamocarb Hydrochloride (375 g/l), 31% Chlorothalonil (375 g/l) Hazardous components
3. HAZARDS IDENTIFICATION
Risk advice to man and the environment
Harmful by inhalation.
Limited evidence of a carcinogenic effect.
Risk of serious damage to eyes.
May cause sensitization by skin contact.
Very toxic to aquatic organisms, may cause long-term adverse effects in the aquatic environment.
4. FIRST AID MEASURES
Remove contaminated clothing immediately and dispose ofsafely.
SAFETY DATA SHEET according to EC Directive 2001/58/EC Move the patient to fresh air and keep at rest. If signs ofpoisoning occur, call a physician immediately.
Wash off immediately with soap and plenty of water. If skinproblems persist, seek medical advice.
In the case of contact with eyes, rinse immediately with plentyof water and seek medical advice.
Do not induce vomiting. Rinse out mouth and give plenty ofwater to drink. Administer activated charcoal. Call a physicianimmediately.
Notes to physician
gastrointestinal discomfort, Eye and mucous membraneirritation, erythema, sensitization, bloody urine risk of respiratory disordersThis product, although being a carbamate, is NOT acholinesterase inhibitor.
Treat symptomatically.
Treat skin and mucous membranes with antihistamine andcorticoids.
By irritation of the lungs: First treatment with Corticord-Spray,e.g.Auxilon, Pulmicort - Dosing aerosol. (Auxilon and Pulmicortare registered Trade Marks)In the event of a mouthful or more being ingested, the followingmeasures should be considered:Gastric lavage with charcoal, if necessary further treatment.
N-Acetylcysteine (Fluimucil; registered trademark)Monitor kidney and respiratory functions.
5. FIRE-FIGHTING MEASURES
Product itself is non-combustible; fire extinguishing measures Cool closed containers exposed to fire with water spray.
Use self-contained breathing apparatus.
Collect contaminated fire extinguishing water separately. Thismust not be discharged into drains.
6. ACCIDENTAL RELEASE MEASURES
Wear personal protective equipment. Unprotected personsmust be kept away.
SAFETY DATA SHEET according to EC Directive 2001/58/EC Keep people and animals away.
Do not discharge into the drains/surface water/groundwater.
If spillage enters drains leading to sewage works inform localwater company immediately.
If spillage enters rivers or watercourses, inform theEnvironment Agency (emergency telephone number 0800807060).
Take up with absorbent material (e.g. sand, earth or aproprietary absorbent material).
Dispose of contaminated material as prescribed Information regarding personal protective equipment, seesection 8.
Information regarding waste disposal, see section 13.
7. HANDLING AND STORAGE
Handling
Prevent penetration into the ground.
Protect against sunrays.
Protect against frost.
Do not store together with foodstuffs.
Stable under recommended storage conditions.
8. EXPOSURE CONTROLS / PERSONAL PROTECTION
Refer to COSHH assessment (Control of substances Hazardous to Health Regulations 1999 asamended). Engineering controls should be used in preference to personal protective equipmentwherever practicable.
SAFETY DATA SHEET according to EC Directive 2001/58/EC Components with workplace control parameters
Engineering measures
See chapter 7; no measures exceeding those mentioned are necessary.
Personal protective equipment
Breathing apparatus needed only when aerosol or mist isformed.
Full mask with combination filter A2/P3.
Keep away from food, drink and animal feeding stuffs.
Remove soiled clothing immediately.
Avoid contact with the skin and the eyes.
After worktime and during work intervals the affected skinareas must be thoroughly cleaned.
9. PHYSICAL AND CHEMICAL PROPERTIES
Appearance
Safety data
: Note: The product is not self-ignitable.
SAFETY DATA SHEET according to EC Directive 2001/58/EC Note: The value mentioned relates to the active ingredientchlorothalonil.
: Note: The product is not explosive.
10. STABILITY AND REACTIVITY
: No hazardous decomposition products known.
: Note: No decomposition if used as directed.
11. TOXICOLOGICAL INFORMATION
rabbitResult: Risk of serious damage to eyes.
OECD 406, Buehler test guinea pigResult: sensitizingMethod: OECD 406, Buehler test Indication of a possible carcinogenic activity in animal tests.
12. ECOLOGICAL INFORMATION
Ecotoxicity effects
semi-static test LC50: 0.177 mg/lRainbow troutExposure time: 96 h semi-static test NOEC: 0.0625 mg/lRainbow troutExposure time: 96 h SAFETY DATA SHEET according to EC Directive 2001/58/EC static testEC50: 0.46 mg/lDaphniaExposure time: 48 h static testNOEC: 0.2 mg/lDaphniaExposure time: 48 h Further information on ecology
The product should not be allowed to reach either ground or open waters.
The product should not be allowed to reach either sewagewaters or water purification plants.
Very toxic to aquatic organisms.
13. DISPOSAL CONSIDERATIONS
In accordance with current regulations may be taken to wastedisposal site or incineration plant, after consultation with siteoperator and/or with the responsible authorityCan be landfilled or incinerated, when in compliance with localregulations.
Advice may be obtained from the local waste regulationauthority (part of the Environment Agency in the UK).
Packaging that cannot be cleaned should be disposed of asproduct waste.
Empty containers can be landfilled, when in compliance withthe Environmental Protection (Duty of Care) Regulations 1991.
14. TRANSPORT INFORMATION
3082 ENVIRONMENTALLY HAZARDOUSSUBSTANCE, LIQUID, N.O.S.
( CHLOROTHALONIL SOLUTION ) SAFETY DATA SHEET according to EC Directive 2001/58/EC 3082 Environmentally hazardous substance, liquid,n.o.s.
( CHLOROTHALONIL SOLUTION ) ENVIRONMENTALLY HAZARDOUSSUBSTANCE, LIQUID, N.O.S.
( CHLOROTHALONIL SOLUTION ) Environmentally hazardous substance, liquid,n.o.s.
( CHLOROTHALONIL SOLUTION ) ENVIRONMENTALLY HAZARDOUSSUBSTANCE, LIQUID, N.O.S.
(CHLOROTHALONIL) 15. REGULATORY INFORMATION
This product has been classified in accordance with The Chemicals (Hazard Information andPackaging for Supply) Regulations 2002: CHIP 3.
Hazardous components which must be listed on the label: Limited evidence of a carcinogenic effect.
May cause sensitization by skin contact.
Very toxic to aquatic organisms, may causelong-term adverse effects in the aquaticenvironment.
SAFETY DATA SHEET according to EC Directive 2001/58/EC In case of contact with eyes, rinseimmediately with plenty of water and seekmedical advice.
This material and its container must bedisposed of in a safe way.
Wear suitable protective clothing, glovesand eye/face protection.
Use appropriate containment to avoidenvironmental contamination.
To avoid risks to man and the environment, comply with theinstructions for use.
16. OTHER INFORMATION
Further information
Text of R phrases mentioned in Section 2: Limited evidence of a carcinogenic effect.
Very toxic to aquatic organisms, may cause long-term adverse effects in theaquatic environment.
The above information is intended to give general health and safety guidance on the storage andtransport of the product.
It is not intended to apply to the use of the product for which purposes the product label and anyappropriate technical usage literature available should be consulted and any relevant licenses,consents or approvals complied with.
The requirements or recommendations of any relevant site or working procedure, system orpolicy in force or arising from any risk assessment involving the substance or product shouldtake precedence over any of the guidance contained in this safety data sheet where there is adifference in the information given.
The information provided in this safety data sheet is accurate at the date of publication and willbe updated as and when appropriate.
No liability will be accepted for any injury, loss or damage resulting from any failure to takeaccount of information or advice contained in this safety data sheet.
Changes since the last version will be highlighted in the margin. This version replaces allprevious versions.

Source: http://www.jdrutherford.co.uk/pdf/msds/MSDS_M/Merlin.pdf

Case-merriman.indd

Case Study #4 Non-alcoholic fatty liver disease: A weighty issue Raphael B. Merriman Learning objectives On completion of this activity, participants should be able to: Discuss the role of liver biopsy in the evaluation of non-alcoholic fatty liver disease (NAFLD) Review emerging non-invasive methods of assessing the severity of NAFLD Outline current therapeutic stra

Dual branding of drugs by the industry is confusing and should be stopped

For personal use only. Not to be reproduced without permission of the editor (permissions@pharmj.org.uk) Dual branding of drugs by the industryis confusing and should be stoppedBy Stein Lyftingsmo , a hospital pharmacist from Elverum, Norway, who has a special interest in packaging and medicines information B efore the medicine was withdrawn from dosage of bupropion:Zyban and Wellbutri

Copyright © 2010-2014 Health Drug Pdf